Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.
Johnson
Paul D R
PD
Department of Infectious Diseases, Austin Health, Heidelberg, Australia. PaulJohnson@austin.org
Stinear
Timothy
T
Small
Pamela L C
PL
Pluschke
Gerd
G
Merritt
Richard W
RW
Portaels
Francoise
F
Huygen
Kris
K
Hayman
John A
JA
Asiedu
Kingsley
K
D000349:Africa / Q000453:epidemiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology* / Q000601:surgery; D019911:Mycobacterium ulcerans / Q000472:pathogenicity*; D011379:Prognosis; D011634:Public Health; D012883:Skin Ulcer / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000503:physiopathology* / Q000601:surgery; D014944:World Health Organization
D000900:Anti-Bacterial Agents